Plan panel targets $100 bn for pharma by 2020
- PDP, BJP seal alliance to form government in Jammu & Kashmir
- RK Pachauri, accused of sexual harassment, quits UN climate change panel
- Centre's land bill is anti-farmer, says Kejriwal at Anna protest rally
- SpiceJet launches low-fare offer for Holi; one lakh seats on the block
- BJP defends Bhagwat, claims Mother Teresa admitted she was not a social worker
The Planning Commission has set a target for the Indian pharmaceutical industry to reach $100 billion by 2020 and account for 5 per cent share of the global drug industry in the next five years.
According to the final draft for 12th Five Year Plan (2012-17) by the panel, the objective of the sector will be to cross the $60 billion mark in 2017, which will be 5 per cent of global pharma industry.
"By 2020, the (pharma) sector should be at $100 billion," it said. Currently, the Indian pharmaceutical industry is valued at $22 billion and is the third largest in terms of volume and 13th in terms of value globally.
According to the draft plan, the exports of pharma products should rise to Rs 1.3 lakh crore by the end of the 12th Five Year Plan. "The sector should employ 15 lakh people by 2015, 18.98 lakh by 2018 and 24.64 lakh people by 2022," it added.
According to the draft plan, which will be submitted to National Development Council on Wednesday, all the Central public sector units producing pharmaceuticals should be self-sustaining by 2020. In order to achieve the target, the Planning Commission has recommended capacity building of private sector to meet WHO standards and other global norms.